Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News

Medicaid expansion increases access to HIV prevention medication for high-risk populations

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

Pneumocystis pneumonia is striking unexpected patient groups, study shows

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia confirms 3 Marburg virus deaths in new outbreak

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Keto diet stops a young girl's epileptic seizures

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

High disease burden found among at-risk Medicaid beneficiaries

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Trial evaluates a vitamin B3 derivative in people with long COVID

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

Todays Updates

New 3-Year EMBARK Data Highlights Continued Therapeutic Effect of Gene Therapy Elevidys in Duchenne Marco Meglio

New findings from the EMBARK study highlight Elevidys' significant long-term benefits in slowing Duchenne muscular dystrophy progression in young patients.

Higher CTE Stages Linked to Increased Dementia Risk, Postmortem Analysis Shows Louie Pasculli

A study of 614 brain donors revealed that individuals with stage III or IV CTE face the greatest risk of dementia.

FDA Approves First Dual-Agent Eye Drop for Near Vision Loss

FDA Approves First Dual-Agent Eye Drop for Near Vision Loss

Todays Updates

New 3-Year EMBARK Data Highlights Continued Therapeutic Effect of Gene Therapy Elevidys in Duchenne Marco Meglio

New findings from the EMBARK study highlight Elevidys' significant long-term benefits in slowing Duchenne muscular dystrophy progression in young patients.

Higher CTE Stages Linked to Increased Dementia Risk, Postmortem Analysis Shows Louie Pasculli

A study of 614 brain donors revealed that individuals with stage III or IV CTE face the greatest risk of dementia.

FDA Approves First Dual-Agent Eye Drop for Near Vision Loss

FDA Approves First Dual-Agent Eye Drop for Near Vision Loss

Latest News

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

A seven-year study of 470 patients revealed that a severe fungal lung infection once mainly seen in specific high-risk groups is increasingly affecting elderly patients and those with common cancers who are not receiving ...

Ethiopia on Monday confirmed three deaths from the Marburg hemorrhagic virus that has been detected in an area neighboring South Sudan.

Alana "Lani" Silverberg was a real firecracker with a big personality at age 3—until she started having seizures.

Over 40% of the 5 million people at risk of losing Medicaid coverage due to new eligibility requirements have at least three chronic health conditions, and older adults are especially vulnerable, a new JAMA study shows.

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issues such as "brain fog," ...

News All Time

Researchers to test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.

Monoclonal antibodies effectively prevent respiratory syncytial virus in infants

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six months of age or people ...

Preliminary case of bird flu in Washington state would be U.S.'s first in 9 months

Health officials in Washington state say they have identified the nation's first human case of bird flu since February, pending confirmatory testing.

Overlooked layer of DNA may explain disease risk, severity

Scientists at The Hospital for Sick Children (SickKids) have revealed a previously overlooked layer of genetic variation that could help explain why people experience disease differently, and why some treatments work better ...

Reversing fibrosis: New research provides insight for novel therapies

Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as scleroderma and graft-versus-host disease.

Ethiopia confirms first Marburg outbreak as WHO lauds country's fast action

Ethiopia on Friday confirmed its first Marburg outbreak after nine cases were identified in a southern region of the country that borders South Sudan.

Metabolic hormone found to boost resilience against flu symptoms

A hormone known for regulating energy balance also helps the body cope with influenza by triggering protective responses in the brain, a study led by UT Southwestern Medical Center researchers shows.

Measles case confirmed in southwestern Colorado, possible exposures in Cortez, Mancos

People in Cortez and Mancos may have been exposed to the measles from a confirmed case in a school-aged child in Montezuma County, according to the Colorado Department of Public Health and Environment.

Typhoid conjugate vaccine demonstrates strong safety and immunogenicity in Phase III trial

Phase III results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj. Multi-dose, demonstrate that it is safe and immunogenic in typhoid-endemic populations in sub-Saharan Africa. EuTYPH-C Inj. Multi-dose ...

First death linked to 'meat allergy' spread by ticks

University of Virginia School of Medicine researchers have identified the first death caused by what is commonly called the "meat allergy" being spread by ticks.

Testing lung function earlier may help identify risk for COPD

Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study published in the September ...

Ethiopia investigates possible outbreak of new viral hemorrhagic fever after 8 people are infected

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were reported.

COP30 report reveals how climate change is spreading infectious diseases to new regions

Rising temperatures, changing rainfall patterns and extreme weather events create ideal conditions for pathogens and their vectors—such as mosquitoes, midges and ticks—to thrive.

Headaches affect almost a third of people worldwide

Do you have regular migraine headaches? If so, you've got a lot of company.

Stinky socks help replace human bait in surveys for river blindness

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies that spread river blindness (onchocerciasis). The study by international non‐profit Sightsavers in ...

Q&A: Why experts urge continued hepatitis B vaccine birth doses for newborns

In a commentary published in Gastroenterology, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth.

Recommended News For You

A garden can save your life

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

"We Caught It Early": Advantage or Disadvantage?

Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.

Recommended Articles For You

Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy 

Advancements in Cancer Treatment and Survival Outcomes for Acute Myeloid Leukemia 

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health 

Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

2.

AI-based liquid biopsy shows promise for detecting brain cancer

3.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

4.

When Should Immunocompromised Individuals Receive a COVID Booster?

5.

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

1.

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications

2.

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy

3.

Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways

4.

CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights

5.

Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot